Soy consumption and phytoestrogens: Effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men

Journal of Urology

Volumn 169, Issue 2, 2003, Pages 507-511

  Jenkins, David J A ^a,b   Kendall, Cyril W C ^a,b   D'Costa, Mario A ^a,b   Jackson, Chung Ja ^a,b   Vidgen, Edward ^a,b   Singer, William ^a,b   Silverman, Jason A ^a,b   Koumbridis, George ^a,b   Honey, John ^a,b   Rao, A Venket ^a,b   Fleshner, Neil ^a,b   Klotz, Laurence ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Androgens, phytotherapy; Isoflavones; Neoplasms, hormone dependent; Prostate

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOESTROGEN; PROSTATE SPECIFIC ANTIGEN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIETARY INTAKE; FOOD INTAKE; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; MALE GENITAL TRACT CANCER; PHYTOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; SOYBEAN;

EID: 0037307213     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)63944-4     Document Type: Article

References (28)

1. Harrison, P. T.: Endocrine disrupters and human health. BMJ, 323: 1317, 2001
2. Messina, M. J., Persky, V., Setchell, K. D. and Barnes, S.: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer, 21: 113, 1994
3. Adlercreutz, H., Mazur, W., Bartels, P., Elomaa, V., Watanabe, S., Wahala, K. et al: Phytoestrogens and prostate disease. J Nutr, 130: 658S, 2000
4. DiPaola, R. S., Zhang, H., Lambert, G. H., Meeker, R., Licitra, E., Rafi, M. M. et al: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med, 339: 785, 1998
5. Affenito, S. G. and Kerstetter, J.: Position of the American Dietetic Association and Dietitians of Canada: women's health and nutrition. J Am Diet Assoc, 99: 738, 1999
6. Adlercreutz, H., Markkanen, H. and Watanabe, S.: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet, 342: 1209, 1993
7. Jacobsen, B. K., Knutsen, S. F. and Fraser, G. E.: Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control, 9: 553, 1998
8. Geller, J., Sionit, L., Pastido, C., Li, L., Tan, X., Younggkin, T. et al: Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate, 34: 75, 1998
9. Anderson, J. W., Johnstone, B. M. and Cook-Newell, M. E.: Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med, 333: 276, 1995
10. Food labeling: Health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist, 64: 57700, 1999
11. Jenkins, D. J., Kendall, C. W., Mehling, C. C., Parker, T., Rao, A. V., Agarwal, S. et al: Combined effect of vegetable protein (soy) and soluble fiber added to a standard cholesterollowering diet. Metabolism, 48: 809, 1999
12. Jenkins, D. J., Kendall, C. W., Vidgen, E., Mehling, C. C., Parker, T., Seyler, H. et al: The effect on serum lipids and oxidized low-density lipoprotein of supplementing self-selected low-fat diets with soluble-fiber, soy, and vegetable protein foods. Metabolism, 49: 67, 2000
13. Jenkins, D. J., Kendall, C. W., Vidgen, E., Vuksan, V., Jackson, C. J., Augustin, L. S. et al: Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism, 49: 1496, 2000
14. Jenkins, D. J., Kendall, C. W., Jackson, C. J., Connelly, P. W., Parker, T., Faulkner, D. et al: Effects of high- and lowisoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr, 76: 365, 2002
15. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. Leuprolide Study Group. N Engl J Med, 311: 1281, 1984
16. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA, 273: 289, 1995
17. Bluestein, B., Zhou, A., Tewari, P., Comerci, C., Schubert, W. et al: Multi-site evaluation of an automated chemiluminescent immunoassay for prostate specific antigen (ACS PSA). J Tumor Marker Oncol, 7: 41, 1992
18. Urban, D., Irwin, W., Kirk, M., Markiewicz, M. A., Myers, R., Smith, M. et al: The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urol, 165: 294, 2001
19. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A. et al: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA, 279: 1542, 1998
20. Zava, D. T. and Duwe, G.: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer, 27: 31, 1997
21. Hsieh, C. Y., Santell, R. C., Haslam, S. Z. and Helferich, W. G.: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res, 58: 3833, 1998
22. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N. et al: Genistein, a specific inhibitor of tyrosinespecific protein kinases. J Biol Chem, 262: 5592, 1987
23. Peterson, T. G. and Barnes, S.: Genistein and biochanin A inhibit growth of human prostate cancer cells, but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate, 22: 335, 1993
24. Tikkanen, M. J., Wahala, K., Ojala, S., Vihma, V. and Adlercreutz, H.: Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci, 95: 3106, 1998
25. Wiseman, H., O'Reilly, J. D., Adlercreutz, H., Mallet, A. I., Bowey, E. A., Rowland, I. R. et al: Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr, 72: 395, 2000
26. Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., Hartman, A. M. et al: Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90: 440, 1998
27. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A. and Willett, W. C.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst, 87: 1767, 1995
28. Malins, D. C., Johnson, P. M., Wheeler, T. M., Barker, E. A., Polissar, N. L. and Vinson, M. A.: Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res, 61: 6025, 2001